cached image

Doug Portman - Publications

University of Rochester, Rochester, NY 
C. elegans, behavior, development, genetics, sex differences

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Alcedo J, Jin Y, Portman DS, Prahlad V, Raizen D, Rapti G, Xu XZS, Zhang Y, Wu CF. Nature's gift to neuroscience. Journal of Neurogenetics. 34: 223-224. PMID 33446019 DOI: 10.1080/01677063.2020.1841760  0.04
2020 Portman DS. Social and sexual behaviors in : the first fifty years. Journal of Neurogenetics. 1-6. PMID 33146579 DOI: 10.1080/01677063.2020.1838512  0.01
2020 Lawson HN, Wexler LR, Wnuk HK, Portman DS. Dynamic, Non-binary Specification of Sexual State in the C. elegans Nervous System. Current Biology : Cb. PMID 32707065 DOI: 10.1016/J.Cub.2020.07.007  0.01
2020 Wexler LR, Miller RM, Portman DS. C. elegans Males Integrate Food Signals and Biological Sex to Modulate State-Dependent Chemosensation and Behavioral Prioritization. Current Biology : Cb. PMID 32531276 DOI: 10.1016/J.Cub.2020.05.006  1
2019 Portman DS. Neural networks mapped in both sexes of the worm. Nature. 571: 40-42. PMID 31270489 DOI: 10.1038/D41586-019-02006-8  0.01
2019 Lawson H, Vuong E, Miller RM, Kiontke K, Fitch DH, Portman DS. The Makorin and the lncRNA regulate to schedule sexual maturation of the nervous system. Elife. 8. PMID 31264582 DOI: 10.7554/Elife.43660  1
2019 Kiontke KC, Herrera RA, Vuong E, Luo J, Schwarz EM, Fitch DHA, Portman DS. The Long Non-Coding RNA lep-5 Promotes the Juvenile-to-Adult Transition by Destabilizing LIN-28. Developmental Cell. PMID 30956008 DOI: 10.1016/J.Devcel.2019.03.003  0.01
2019 Pereira L, Aeschimann F, Wang C, Lawson H, Serrano-Saiz E, Portman DS, Großhans H, Hobert O. Timing mechanism of sexually dimorphic nervous system differentiation. Elife. 8. PMID 30599092 DOI: 10.7554/Elife.42078  0.01
2018 Fagan KA, Luo J, Lagoy RC, Schroeder FC, Albrecht DR, Portman DS. A Single-Neuron Chemosensory Switch Determines the Valence of a Sexually Dimorphic Sensory Behavior. Current Biology : Cb. PMID 29526590 DOI: 10.1016/J.Cub.2018.02.029  1
2018 Barr MM, García LR, Portman DS. Sexual Dimorphism and Sex Differences inNeuronal Development and Behavior. Genetics. 208: 909-935. PMID 29487147 DOI: 10.1534/Genetics.117.300294  0.01
2017 Portman DS. Sexual modulation of sex-shared neurons and circuits in Caenorhabditis elegans. Journal of Neuroscience Research. 95: 527-538. PMID 27870393 DOI: 10.1002/Jnr.23912  0.01
2016 Portman DS. Neurobiology: Wired for sex. Nature. 533: 188-9. PMID 27144358 DOI: 10.1038/Nature17898  0.01
2016 Portman DS, Biteau B. Neuter No More: Fly Stem Cells Know Their Sex. Cell Stem Cell. 18: 429-30. PMID 27058932 DOI: 10.1016/J.Stem.2016.03.009  0.01
2016 García LR, Portman DS. Neural circuits for sexually dimorphic and sexually divergent behaviors in Caenorhabditis elegans. Current Opinion in Neurobiology. 38: 46-52. PMID 26929998 DOI: 10.1016/J.Conb.2016.02.002  0.01
2015 Labrie F, Derogatis L, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, Beauregard A, Martel C, Vaillancourt M, et al. Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. The Journal of Sexual Medicine. PMID 26597311 DOI: 10.1111/jsm.13045  1
2015 Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dubé R. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. Menopause (New York, N.Y.). PMID 25968836 DOI: 10.1097/GME.0000000000000470  1
2015 Portman D, Shulman L, Yeaw J, Zeng S, Uzoigwe C, Maamari R, Iyer NN. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy. Menopause (New York, N.Y.). PMID 25944522 DOI: 10.1097/GME.0000000000000465  1
2015 Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Côté I, Lavoie L, Beauregard A, et al. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 81: 46-56. PMID 25771041 DOI: 10.1016/J.Maturitas.2015.02.005  1
2015 Archer DF, Labrie F, Bouchard C, Portman DJ, Koltun W, Cusan L, Labrie C, Côté I, Lavoie L, Martel C, Balser J. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause (New York, N.Y.). PMID 25734980 DOI: 10.1097/Gme.0000000000000428  1
2015 Sarrel P, Portman D, Lefebvre P, Lafeuille MH, Grittner AM, Fortier J, Gravel J, Duh MS, Aupperle PM. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause (New York, N.Y.). 22: 260-6. PMID 25714236 DOI: 10.1097/GME.0000000000000320  1
2015 Kaunitz AM, Portman D, Westhoff CL, Mishell DR, Archer DF, Foegh M. New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study. Contraception. 91: 211-6. PMID 25586864 DOI: 10.1016/j.contraception.2014.11.013  1
2015 Kaunitz AM, Portman D, Westhoff CL, Archer DF, Mishell DR, Foegh M. Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill. Contraception. 91: 204-10. PMID 25582984 DOI: 10.1016/j.contraception.2014.11.011  1
2015 Bouchard C, Labrie F, Archer DF, Portman DJ, Koltun W, Elfassi É, Grainger DA, Ayotte N, Cooper TA, Martens M, Waldbaum AS, Labrie C, Côté I, Lavoie L, Martel C, et al. Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric : the Journal of the International Menopause Society. 18: 590-607. PMID 25511551 DOI: 10.3109/13697137.2014.992012  1
2015 Constantine G, Graham S, Portman DJ, Rosen RC, Kingsberg SA. Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial. Climacteric : the Journal of the International Menopause Society. 18: 226-32. PMID 25252699 DOI: 10.3109/13697137.2014.954996  1
2015 Albizu-Rivera A, Portman DG, Thirlwell S, Codada SN, Donovan KA. Implementation of NCCN Palliative Care Guidelines by member institutions Supportive Care in Cancer. DOI: 10.1007/s00520-015-2862-y  1
2015 Portman D, Thirlwell S. Perspectives, progress, and opportunities for palliative care in oncology Cancer Control. 22: 382-384.  1
2014 Ryan DA, Miller RM, Lee K, Neal SJ, Fagan KA, Sengupta P, Portman DS. Sex, age, and hunger regulate behavioral prioritization through dynamic modulation of chemoreceptor expression. Current Biology : Cb. 24: 2509-17. PMID 25438941 DOI: 10.1016/J.Cub.2014.09.032  1
2014 Portman DJ, Gass MLS, Kingsberg S, Archer D, Bachmann G, Burrows L, Freedman M, Goldstein A, Goldstein I, Heller D, Iglesia CB, Kagan R, Spadt SK, Krychman M, Nachtigall L, et al. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the international society for the study of women's sexual health and the North American Menopause Society Menopause. 21: 1063-1068. PMID 25160739 DOI: 10.1097/gme.0000000000000329  1
2014 Fagan KA, Portman DS. Sexual modulation of neural circuits and behavior in Caenorhabditis elegans. Seminars in Cell & Developmental Biology. 33: 3-9. PMID 24937129 DOI: 10.1016/J.Semcdb.2014.06.007  1
2014 Kaunitz AM, Portman D, Westhoff CL, Archer DF, Mishell DR, Foegh M. In reply. Obstetrics and Gynecology. 123: 1108. PMID 24785870 DOI: 10.1097/AOG.0000000000000248  1
2014 Portman D, Palacios S, Nappi RE, Mueck AO. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial Maturitas. 78: 91-98. PMID 24679891 DOI: 10.1016/j.maturitas.2014.02.015  1
2014 Portman DJ, Kaunitz AM, Howard B, Weiss H, Hsieh J, Ricciotti N. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception. 89: 299-306. PMID 24576794 DOI: 10.1016/j.contraception.2014.01.013  1
2014 Portman DJ, Kaunitz AM, Kazempour K, Mekonnen H, Bhaskar S, Lippman J. Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause (New York, N.Y.). 21: 1082-90. PMID 24552977 DOI: 10.1097/GME.0000000000000210  1
2014 Mowrey WR, Bennett JR, Portman DS. Distributed effects of biological sex define sex-typical motor behavior in Caenorhabditis elegans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 1579-91. PMID 24478342 DOI: 10.1523/Jneurosci.4352-13.2014  1
2014 Simon J, Portman D, Mabey RG. Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women. Maturitas. 77: 274-81. PMID 24411556 DOI: 10.1016/j.maturitas.2013.12.005  1
2014 Kaunitz AM, Portman D, Westhoff CL, Archer DF, Mishell DR, Rubin A, Foegh M. Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial. Obstetrics and Gynecology. 123: 295-303. PMID 24402597 DOI: 10.1097/AOG.0000000000000095  1
2014 Pinkerton JV, Kagan R, Portman D, Sathyanarayana R, Sweeney M. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause Menopause. 21: 567-573. PMID 24149930 DOI: 10.1097/GME.0b013e3182a7c073  1
2014 Goldstein SR, Bachmann GA, Koninckx PR, Lin VH, Portman DJ, Ylikorkala O. Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric : the Journal of the International Menopause Society. 17: 173-82. PMID 23984673 DOI: 10.3109/13697137.2013.834493  1
2014 Portman DJ, Gass MLS. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society Maturitas. DOI: 10.1016/j.maturitas.2014.07.013  1
2013 Simon JA, Portman DJ, Kaunitz AM, Mekonnen H, Kazempour K, Bhaskar S, Lippman J. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause (New York, N.Y.). 20: 1027-35. PMID 24045678 DOI: 10.1097/GME.0b013e3182a66aa7  1
2013 Trussell J, Portman D. The creeping pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills? Contraception. 88: 604-610. PMID 23683581 DOI: 10.1016/J.Contraception.2013.04.001  1
2013 Portman DJ, Bachmann GA, Simon JA. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause (New York, N.Y.). 20: 623-30. PMID 23361170 DOI: 10.1097/gme.0b013e318279ba64  1
2012 Mowrey WR, Portman DS. Sex differences in behavioral decision-making and the modulation of shared neural circuits. Biology of Sex Differences. 3: 8. PMID 22436578 DOI: 10.1186/2042-6410-3-8  1
2011 Siehr MS, Koo PK, Sherlekar AL, Bian X, Bunkers MR, Miller RM, Portman DS, Lints R. Multiple doublesex-related genes specify critical cell fates in a C. elegans male neural circuit. Plos One. 6: e26811. PMID 22069471 DOI: 10.1371/Journal.Pone.0026811  1
2011 Miller RM, Portman DS. The Wnt/beta-catenin asymmetry pathway patterns the atonal ortholog lin-32 to diversify cell fate in a Caenorhabditis elegans sensory lineage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13281-91. PMID 21917811 DOI: 10.1523/Jneurosci.6504-10.2011  1
2010 Hurd DD, Miller RM, Núñez L, Portman DS. Specific alpha- and beta-tubulin isotypes optimize the functions of sensory Cilia in Caenorhabditis elegans. Genetics. 185: 883-96. PMID 20421600 DOI: 10.1534/Genetics.110.116996  1
2010 Miller RM, Portman DS. A latent capacity of the C. elegans polycystins to disrupt sensory transduction is repressed by the single-pass ciliary membrane protein CWP-5. Disease Models & Mechanisms. 3: 441-50. PMID 20223935 DOI: 10.1242/Dmm.002816  1
2009 Kaunitz AM, Portman DJ, Hait H, Reape KZ. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive Contraception. 79: 350-355. PMID 19341846 DOI: 10.1016/j.contraception.2008.11.011  1
2009 Aviram H, Portman DL. Inequitable enforcement: Introducing the concept of equity into constitutional review of law enforcement Hastings Law Journal. 61: 413-455.  1
2009 Portman D. Revue de Laryngologie Otologie Rhinologie: Editorial Revue De Laryngologie Otologie Rhinologie. 130: 266.  1
2008 Mason DA, Rabinowitz JS, Portman DS. dmd-3, a doublesex-related gene regulated by tra-1, governs sex-specific morphogenesis in C. elegans. Development (Cambridge, England). 135: 2373-82. PMID 18550714 DOI: 10.1242/Dev.017046  1
2008 Shulman LP, Portman DJ, Lee WC, Balu S, Joshi AV, Cobden D, Wang Q, Pashos CL. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: Implications for clinical practice Journal of Women's Health. 17: 569-578. PMID 18429700 DOI: 10.1089/Jwh.2007.0407  1
2007 Lee K, Portman DS. Neural sex modifies the function of a C. elegans sensory circuit. Current Biology : Cb. 17: 1858-63. PMID 17964163 DOI: 10.1016/J.Cub.2007.10.015  1
2007 Portman DS. Genetic control of sex differences in C. elegans neurobiology and behavior. Advances in Genetics. 59: 1-37. PMID 17888793 DOI: 10.1016/S0065-2660(07)59001-2  1
2007 Portman D. Menopause pharmacotherapeutic development - CBI's second annual conference Idrugs. 10: 178-180. PMID 17351871  1
2006 Portman DS. Profiling C. elegans gene expression with DNA microarrays. Wormbook : the Online Review of C. Elegans Biology. 1-11. PMID 18050445 DOI: 10.1895/Wormbook.1.104.1  1
2006 Anderson FD, Gibbons W, Portman D. Long-term safety of an extended-cycle oral contraceptive (Seasonale): A 2-year multicenter open-label extension trial American Journal of Obstetrics and Gynecology. 195: 92-96. PMID 16813747 DOI: 10.1016/j.ajog.2005.12.045  1
2006 Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol Contraception. 73: 229-234. PMID 16472561 DOI: 10.1016/j.contraception.2005.09.010  1
2005 Portman D. Suspension bridges History of Technology. 26.  1
2004 Portman DS, Bohmann D. Toward the computable transcriptome. Molecular Cell. 14: 693-4. PMID 15200946 DOI: 10.1016/J.Molcel.2004.06.013  1
2004 Portman DS, Emmons SW. Identification of C. elegans sensory ray genes using whole-genome expression profiling. Developmental Biology. 270: 499-512. PMID 15183729 DOI: 10.1016/J.Ydbio.2004.02.020  1
2004 Portman D, Lee N. Henry Marc Brunel: Civil engineer Construction History. 20: 71-83.  1
2003 Anderson FD, Hait H, Baldwin D, Kerber I, Moffet A, Simon JA, Kreutner K, Angelo J, Barbier S, Blumenthal P, Chavez A, Cooley N, Cooper J, D'Andrea V, Davies T, ... ... Portman D, et al. A multicenter, randomized study of an extended cycle oral contraceptive Contraception. 68: 89-96. PMID 12954519 DOI: 10.1016/S0010-7824(03)00141-0  1
2003 Portman DJ, Symons JP, Wilborn W, Kempfert NJ. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone American Journal of Obstetrics and Gynecology. 188: 334-342. PMID 12592236 DOI: 10.1067/mob.2003.91  1
2003 Wang WC, Portman D, Gong G, Zhang P, Karl T. Beijing summer temperatures since 1724 Climate Since a.D. 1500: Revised Edition. 210-223. DOI: 10.4324/9780203430996  1
2002 Portman D. A business history of the Clifton Suspension Bridge Construction History. 18: 3-20.  1
2001 Simon JA, Symons JP, Marcadis A, Nunez M, Guarneri J, Stoukides J, Miaskiewicz SL, Corm L, Stuccio-White N, Corbin R, Gutierrez M, Weiss S, Portman D, Wolff R, Marx P, et al. Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: A direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens Menopause. 8: 321-327. PMID 11528357  1
2000 Portman DS, Emmons SW. The basic helix-loop-helix transcription factors LIN-32 and HLH-2 function together in multiple steps of a C. elegans neuronal sublineage. Development (Cambridge, England). 127: 5415-26. PMID 11076762  1
2000 Duncan B, Portman D, Bey I, Spivakovsky C. Parameterization of OH for efficient computation in chemical tracer models Journal of Geophysical Research: Atmospheres. 105: 12259-12262.  1
1998 Hassfeld W, Chan EK, Mathison DA, Portman D, Dreyfuss G, Steiner G, Tan EM. Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P. Nucleic Acids Research. 26: 439-45. PMID 9421497 DOI: 10.1093/Nar/26.2.439  1
1997 Portman DS, O'Connor JP, Dreyfuss G. YRA1, an essential Saccharomyces cerevisiae gene, encodes a novel nuclear protein with RNA annealing activity. Rna (New York, N.Y.). 3: 527-37. PMID 9149233  1
1996 Portman DA, Gutzler DS. Explosive volcanic eruptions, the El Niño-Southern oscillation, and U.S. climate variability Journal of Climate. 9: 17-33.  1
1995 Kamma H, Portman DS, Dreyfuss G. Cell type-specific expression of hnRNP proteins. Experimental Cell Research. 221: 187-96. PMID 7589244 DOI: 10.1006/Excr.1995.1366  1
1994 Portman DS, Dreyfuss G. RNA annealing activities in HeLa nuclei. The Embo Journal. 13: 213-21. PMID 7508381 DOI: 10.1002/J.1460-2075.1994.Tb06251.X  1
1993 Görlach M, Burd CG, Portman DS, Dreyfuss G. The hnRNP proteins. Molecular Biology Reports. 18: 73-8. PMID 8232298 DOI: 10.1007/Bf00986759  1
1993 Portman DA. Identifying and correcting urban bias in regional time series: surface temperature in China's northern plains Journal of Climate. 6: 2298-2308.  1
1985 Portman R, Portman D. Cost containment factors will dictate promotional changes. Medical Marketing & Media. 20: 30-33, 36. PMID 10269483  1
Show low-probability matches.